Lyme Fraud Explainer, Simple Version


If you all could just print these out and put them all together in one
place, and llook at them as one relatively small package of data, you
will see how Lyme is scientific fraud.

First for the fun stuff: Edward McSweegan and Durland Fish conspire to
send the Lyme Foundation "a bogus article." and see how Allen
Steere changed the standard for Lyme from his original one where
changing and expanding IgM and IgG antibodies were diagnostic of Lyme
to one where only IgG should be analyzed (Jail4U Allen Boyo).

1) The attached document is a graphical explainer on how people with
neuroborreliosis don't tend to have the hypersensitivity reaction
(allergy) to Borrelial lipoproteins. That is, they have a lower
concentration of antibodies, to their Western Blots appear faint (and
this link now works):

2) This is a Yale report, which is about 5 pages, and in the last few
paragraphs, Yale's Erol Fikrig is discussing what is wrong with OspA
vaccination- read especially the last few paragraphs:

3) This is the original CDC standard, in which Allen Steere describes
Lyme borreliosis as a relapsing fever organism, and that ***changing
and expanding IgM and IgG antibodies is diagnostic*** (see the last few
paragraphs, at least):
Later CDC left these IgM antibodies basically out of the serodiagnostic
standard. (The consensus is that no one figure out what CDC thinks
they are doing.)

4) Here is the CDC saying the same thing in 1990:

5) Here is myself, explaining what happened with LymeRIX, and what
happened at Dearborn, only those last couple of pages were put on the
FDA's website in the wrong order:

6) Here is the Yale Flagellin method, which is about 94% accurate:
As you can see, Daniel Rahn is an author of that report.
The US patent for that is 5,618,533, and was applied for in 1993.

7) Here is Pam3Cys, which is what is unique about OspA (LymeRIX):
Immune suppression/dysregulation.

8) Here is Corixa and SmithKline now joined as one company, creating
allergy vaccines based on what they learned about OspA, and part of the
story is that some people are immune suppressed due to these kinds of
lipoproteins, which are only represented in *fungal* antigens like

THAT IS, people with chronic Lyme, or post-LymeRIX syndrome are immune
suppressed, particularly as regards mycoplasmal and mycobacterial
infections, but also as regards all infections, becuase as you can see,
Yale is also now interested in the damage they have done activating

Which was what Paul Duray noted in 1992 about how lymphocytes of
chronic Lyme patients looked in Steve Schutzer's 1992 book, "Lyme
disease, Molecular and Immunological Approaches."

STARI is a bovine borreliosis.

J Clin Microbiol. 2001 Feb;39(2):494-7. Related Articles, Links
Click here to read Click here to read
Lone star tick-infecting borreliae are most closely related to the
agent of bovine borreliosis.

Rich SM, Armstrong PM, Smith RD, Telford SR 3rd.

Division of Infectious Disease, Tufts University School of
Veterinary Medicine, North Grafton, Massachusetts, USA.

Although Borrelia theileri, the agent of bovine borreliosis, was
described at the turn of the century (in 1903), its relationship with
borreliae causing Lyme disease or relapsing fever remains undescribed.
We tested the previously published hypothesis that spirochetes
infecting Lone Star ticks (Amblyomma
americanum) may comprise B. theileri by analyzing the 16S ribosomal
DNAs (rDNAs) and flagellin genes of these spirochetes. B. theileri, the
Amblyomma agent, and B. miyamotoi formed a natural group or clade
distinct from but most closely related to that of the relapsing fever
spirochetes. B. theileri and the
Amblyomma agent were 97 and 98% similar at the nucleotide level within
the analyzed portions of the 16S rDNA and the flagellin gene
respectively, suggesting a recent divergence. The agent of bovine
borreliosis might be explored as a surrogate antigen for the
as-yet-uncultivatable Amblyomma agent in studies designed to explore
the etiology of a Lyme disease-like infection associated with Lone Star

PMID: 11158095 [PubMed - indexed for MEDLINE]